Serum vitamin D, physical activity and the obstructive sleep apnea syndrome Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012
The association between obstructive sleep apnea syndrome and vitamin D deficiency Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders Year: 2016
The role of vitamin D in obstructive sleep apnoea syndrome Source: Breathe, 14 (3) 206; 10.1183/20734735.000618 Year: 2018
Serum vitamin D levels are associated with markers of hypoxia in obstructive sleep apnea patients Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Vitamin D deficiency and excessive daytime sleepiness in obstructive sleep apnea: Is there a correlation? Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Serum vitamin D levels in patients with obstructive sleep apnea syndrome and concentration changes after continuous positive airway pressure treatment Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020
Association between 25-hydroxyvitamin D and interleukin 17 levels in severe obstructive sleep apnea syndrome Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016
Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
The impact of obstructive sleep apnea syndrome (SAOS) on serum testosterone level Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea Year: 2007
The relationship between obstructive sleep apnea syndrome and apolipoprotein E allels Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Relationship between obstructive sleep apnea syndrome, plasma homocysteine levels and cardiovascular risk Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Serum omentin levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Effects of apolipoprotein E genotype on serum lipids in obstructive sleep apnoea Source: Eur Respir J 2014; 43: 1097-1105 Year: 2014
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004
Does low plasma adiponectin level affect cardiovasculer risk in obstructive sleep apnea syndrome? Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Associations between increased serum leptin levels and the severity of obstructive sleep apnoea independent of obesity Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Relations between cystatin C plasma concentration and cardiovascular complications in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004